1 year return (CAGR)
179.25%
Relmada Therapeutics Inc Exchange (NASDAQ, USD)
RLMD
4.20
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
7.74%
5 year return (CAGR)
-29.38%
10 year return (CAGR)
-6.18%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
473.61M
Price/Sales
-
Ent value
474.78M
Price/Book
2.29
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.44 |
| Daily high | 4.50 |
| Daily low | 4.30 |
| Daily Volume | 1.99M |
| All-time high | 74.40 |
| 1y analyst estimate | 12.40 |
| Beta | 0.83 |
| EPS (TTM) | -0.55 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RLMD | S&P500 | |
| Current price drop from All-time high | -94.35% | -1.96% |
| Highest price drop | -99.66% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -78.78% | -10.68% |
| Avg time to new high | 188 days | 12 days |
| Max time to new high | 2856 days | 1805 days |
News
